NEWTON, Mass.–(BUSINESS WIRE)– #LUMISIGHT–Lumicell’s LumiSystem™ Featured on Viewpoint with Dennis Quaid for New Episode on Fluorescence-Imaging Guidance During Lumpectomy Surgery
Category: Business
Get Hooked on Maui Jim’s New Fishing Style, Keha
PEORIA, Ill.–(BUSINESS WIRE)–Maui Jim set sail on a fishing adventure with the launch of its first activity-specific performance-inspired sport style, Keha 663 and its Asian Fit counterpart Keha Asian Fit 664, on October 8. This quintessential 8-base…
Ora renforce son leadership mondial avec des nominations clés en Europe et dans les services aux personnes
BOSTON–(BUSINESS WIRE)–Ora, leader mondial de la recherche sous contrat en ophtalmologie, a le plaisir d’annoncer les nominations de Marcin Ernst, MD, MBA, au poste de vice-président pour l’Europe, et de Tim Neathery au poste de directeur des ressour…
Riassunto: Ora rafforza la dirigenza globale con nomine chiave in Europa e in People Services
BOSTON–(BUSINESS WIRE)–Ora, la principale azienda di ricerca clinica su contratto (CRO) nel settore oftalmico a livello globale, è lieta di annunciare le nomine di Marcin Ernst, MD, MBA e di Tim Neathery al ruolo, rispettivamente, di Vicepresidente p…
Ora verstevigt haar wereldleiderschap dankzij belangrijke benoemingen in Europa en People Services
BOSTON–(BUSINESS WIRE)–Ora, de toonaangevende internationale CRO (contract research organization) actief in oftalmologie, kondigt met genoegen de benoemingen aan van Marcin Ernst, MD, MBA, tot vicevoorzitter voor Europa, en van Tim Neathery tot Chief…
Resumen: Ora refuerza su liderazgo internacional con nombramientos clave en Europa y servicios a las personas
BOSTON–(BUSINESS WIRE)–Ora, la organización de investigación por contrato (CRO) oftálmica líder en el mundo, se complace en anunciar los nombramientos de Marcin Ernst, doctor en Medicina y máster en Administración de Empresas, como vicepresidente de …
Ora Strengthens Global Leadership with Key Appointments in Europe and People Services
BOSTON–(BUSINESS WIRE)– #clinicalresearch–CRO Ora announces appointments of Dr Marcin Ernst, Vice President of Europe, and Tim Neathery, Chief People Officer, strengthening global leadership.
Riassunto: Nordic Group B.V., attraverso la sua controllata Nordic Pharma, Inc. (Stati Uniti), continua la sua presentazione di LACRIFILL ® Canalicular Gel, una nuova terapia per la sindrome dell'occhio secco, durante il congresso 2024…
BERWYN, Pa.–(BUSINESS WIRE)– Nordic Group B.V., attraverso la sua controllata Nordic Pharma, Inc. (Stati Uniti), continua la sua presentazione di LACRIFILL ® Canalicular Gel, una nuova terapia per la sindrome dell’occhio secco, durante il congresso …
Samenvatting: Via haar dochteronderneming Nordic Pharma, Inc. (U.S.) zet Nordic Group B.V. haar introductie van LACRIFILL® Canalicular Gel, een nieuwe therapie voor droge ogen, verder tijdens de AAO (American Academy of Ophthalmology) 2024
BERWYN, Pa.–(BUSINESS WIRE)–Nordic Pharma, Inc., een dochteronderneming van Nordic Group B.V., lanceerde in april LACRIFILL Canalicular Gel, een nieuwe therapie ter behandeling van droge ogen in de Verenigde Staten en zal haar introductie bij toonaan…
Resumen: Nordic Group B.V. A través de su filial Nordic Pharma, Inc. (EE.UU.), continúa su introducción del gel canalicular LACRIFILL®, una terapia novedosa para el ojo seco, durante la American Academy of Ophthalmology (AAO) 2024
BERWYN, Pensilvania–(BUSINESS WIRE)–Nordic Pharma, Inc, filial de Nordic Group B.V., lanzó en abril en EE.UU. el gel canalicular LACRIFILL, una novedosa terapia para el ojo seco, y continuará su presentación a los principales oftalmólogos durante la …
Nordic Group B.V. präsentiert über ihre Tochtergesellschaft Nordic Pharma, Inc. (U.S.) im Rahmen der American Academy of Ophthalmology (AAO) 2024 die Einführung von LACRIFILL® Canalicular Gel, einer neuartigen Therapie für trockene Augen, fort
BERWYN, Pa.–(BUSINESS WIRE)–Nordic Pharma, Inc., eine Tochtergesellschaft der Nordic Group B.V., brachte im April LACRIFILL Canalicular Gel, eine neuartige Therapie für trockene Augen, in den USA auf den Markt und wird die Einführung bei führenden Au…
Nordic Group B.V., par l'entremise de sa filiale Nordic Pharma, Inc. (U.S.), poursuit l'introduction du gel canaliculaire LACRIFILL®, une thérapie novatrice contre la sécheresse oculaire, durant le congrès 2024 de l'American Academy of…
BERWYN, Pennsylvanie–(BUSINESS WIRE)– Nordic Group B.V., par l’entremise de sa filiale Nordic Pharma, Inc. (U.S.), poursuit l’introduction du gel canaliculaire LACRIFILL®, une thérapie novatrice contre la sécheresse oculaire, durant le congrès 2024 …
Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Continues Its Introduction of LACRIFILL® Canalicular Gel, a Novel Therapy for Dry Eye, During American Academy of Ophthalmology (AAO) 2024
BERWYN, Pa.–(BUSINESS WIRE)–Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., launched LACRIFILL Canalicular Gel, a novel therapy for dry eye in the U.S. in April and will continue its introduction to leading ophthalmologists during AAO 2024. L…
Horizon Surgical Systems Raises $30 Million in Series A Financing
MALIBU, Calif.–(BUSINESS WIRE)–Horizon Surgical Systems, Inc., a privately-held, micro-robotics company advancing microsurgery with automated AI-enabled robotics, announced the close of a $30M Series A financing. The financing was led by ExSight Vent…
Eye Health America and Verséa Ophthalmics, Inc. Enter Into a Preferred Partnership to Support Management of Ocular Surface Disease and Ocular Surgery
GREENVILLE, S.C. & TAMPA, Fla.–(BUSINESS WIRE)– #biovance–Eye Health America and Verséa Ophthalmics, Inc. Enter Into a Preferred Partnership to Support Management of Ocular Surface Disease and Ocular Surgery.
eternalHealth Unveils 2025 Medicare Advantage Plans Focusing on Affordable, High Quality Healthcare and Expanded Coverage
BOSTON–(BUSINESS WIRE)– #Healthcare–eternalHealth, a leading health insurance in Massachusetts and Arizona, announced its 2025 Medicare Advantage plans earlier this week. In a year where Medicare Beneficiaries are looking for stability, eternalHealt…
FDA Grants Clearance for SPECTRALIS Flex Module, Expanding Access to Advanced Multimodal Ophthalmic Imaging for Underserved Patients
FRANKLIN, Mass.–(BUSINESS WIRE)–Heidelberg Engineering, a global leader in ophthalmic imaging and healthcare data solutions, announces FDA clearance of the SPECTRALIS® Flex Module. This innovative, multimodal, diagnostic imaging-only platform is uniq…
Glaukos To Present Multiple Scientific Abstracts at the 2024 American Academy of Ophthalmology Annual Meeting
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that i…
Bausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of Vision Intraocular Lens
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the U.S. Food and Drug Administration has approved the enVist…
MyEyeDr. Teams Up With WNBA Star Allisha Gray For ExamJam Event, Supporting Eye Health In Students
ATLANTA–(BUSINESS WIRE)–MyEyeDr., a leading provider of eye health services with over 850 locations across the U.S., teamed up with two-time WNBA All-Star and 2020 3×3 Basketball Gold Medalist, Allisha Gray to promote the importance of eye health in …